EUVIMEDEUVIMED entdecken
Crossref

HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated With Germline HNF1B Variant

Catherine E Hagen, Dipti M Karamchandani, Luisa Ricaurte, Nagaswaroop Nagaraj, Vivekananda Sarangi, Christopher P Hartley, Chirag Patel, Marcela Salomao, Rish Pai, Rondell P Graham

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Catherine E Hagen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: Hagen.catherine@mayo.edu. Hauptthemen laut MEDLINE: Adenoma, Liver Cell, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 1-beta, Liver Neoplasms. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Mayo Clinic, Department of Pathology and Laboratory Medicine, College of Medicine, Medical University of South Carolina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HNF1A-inactivated hepatocellular adenomas are rarely described in patients with hepatorenal fibrocystic disease, and their genetic relationship remains unexplored. This study reports a series of HNF1A-inactivated hepatocellular adenomas with molecular sequencing analysis in patients with fibrocystic kidney and/or liver disease. Cases were retrospectively identified from the pathology archives of 3 institutions. Clinical history was collected from chart review, and hematoxylin-and-eosin-stained slides along with relevant immunohistochemistry were reviewed for liver specimens. Next-generation sequencing was performed on paired lesional hepatocellular adenoma and nonneoplastic tissue. The study group comprised 8 patients (median age, 25 years; male:female, 1:7). Six patients had evidence of congenital hepatic fibrosis, 1 had polycystic liver disease with multiple cysts and bile duct hamartomas, and 1 had an uninvolved background liver but with polycystic kidney disease. Histologic examination revealed that all hepatocellular adenomas showed circumscribed, well-differentiated hepatocellular proliferation with unpaired arterioles and loss of liver fatty acid-binding protein staining via immunohistochemistry. Three patients were found to have novel HNF1B germline variants (c.1430A>C). Our data reveal a new syndromic association for HNF1A-inactivated hepatocellular adenomas. We hypothesize that aberrant interactions between HNF1A and HNF1B may contribute to the pathogenesis of hepatocellular adenomas in these patients. Further studies are necessary to discover additional germline variants that may result in a similar phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenoma, Liver CellHepatocyte Nuclear Factor 1-alphaHepatocyte Nuclear Factor 1-betaLiver NeoplasmsLiver DiseasesCystsHumansMaleFemaleAdultGerm-Line MutationYoung AdultRetrospective StudiesMiddle AgedAdolescent

Stichwörter der Autor:innen

HNF1AHNF1Bcongenital hepatic fibrosishepatocellular adenomapolycystic kidney diseasepolycystic liver disease

Substanzen

Hepatocyte Nuclear Factor 1-alphaHNF1A protein, humanHepatocyte Nuclear Factor 1-betaHNF1B protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: Hagen.catherine@mayo.edu.
  • Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Now with Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona.

Förderung

  • Mayo Clinic
  • Department of Pathology and Laboratory Medicine, College of Medicine, Medical University of South Carolina

Zitieren

APA

Hagen, C. E., Karamchandani, D. M., Ricaurte, L., Nagaraj, N., Sarangi, V., Hartley, C. P., Patel, C., Salomao, M., Pai, R., & Graham, R. P. (2025). HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated With Germline HNF1B Variant. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100880

Vancouver

Hagen CE, Karamchandani DM, Ricaurte L, Nagaraj N, Sarangi V, Hartley CP, et al. HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated With Germline HNF1B Variant. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100880

BibTeX
@article{Hagen2025,
  author = {Hagen, Catherine E and Karamchandani, Dipti M and Ricaurte, Luisa and Nagaraj, Nagaswaroop and Sarangi, Vivekananda and Hartley, Christopher P and Patel, Chirag and Salomao, Marcela and Pai, Rish and Graham, Rondell P},
  title = {HNF1A-inactived Hepatocellular Adenomas in Fibropolycystic Kidney and Liver Disease Are Associated With Germline HNF1B Variant},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100880}
}
Kostenlos starten →